Point Loma Resources Ltd (PLX) ニュース

$ILLR Undervalued Gem Ready to Shine
🚨 Attention investors: This stock is significantly undervalued, and the market hasn’t caught on yet. With strong fundamentals, a clear growth path, and a motivated management team, this opportunity is a no-brainer for forward-thinking portfolios. D

supported and materially participated in

What does that mean? There were other investors in addition to the Scherrers?

Do you think SDRC really received $8 million?

$LGHL .18 break

Yep, that's the one... I've been here so long that nothing anyone can post would convince me to give up my shares. Especially since I bought so many around the .002 price. I expect a steady accumulation over the next few weeks, up to the PENNYLAND level as George starts to update the audited finan

attempted a buy- funds were not available- will try again tomorrow

Outside the Nov pop....23 months to retrace to these levels.....
AND on actual News.
Welcome back Longs.
It must have been a harrowing ride to 4 and back.
NOW, lets see the Science prove itself.
THEN the $M Club may have some returning members.

Happy

The IVDN Q3 financial filing has been posted today and can be seen at this direct link:
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001190370/000173112224002036/e6233_10q.htm

This was the last overdue filing needed to bring IVDN back to current status. Now that this is f

They should do an offering at 12 or 15. 10M shares. Fund 3-71 properly.

Richland, WA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- – Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy™ in India. This milestone trial, which has commenced with the successful treatment of five patients with cancerou

$ILLR 🚀💡 Savvy Investors, Take Note!
Opportunities like this don’t knock twice. With growth on the horizon and innovative moves in the pipeline, now’s the time to secure your position in a game-changing investment. 📈

💼 Pro Tip: Research, act fast

$ILLR 🚀💡 Savvy Investors, Take Note!
Opportunities like this don’t knock twice. With growth on the horizon and innovative moves in the pipeline, now’s the time to secure your position in a game-changing investment. 📈

💼 Pro Tip: Research, act fast

attempted a buy- funds were not available

the same for me , i have no patience for the loosers..they are blocked directly, I'm not looking for friends.. I'm just dreaming of the day when I can demolish the MM.

$ZEPP Health NYSE Q3 breakdown and deep dive into the company. Very educational. Very interesting https://www.youtube.com/watch?v=3ybdShXg6cs

Ha Ha, appears one is too use to this pattern, aka never gonna happen POS "PHIL" 🤣😂🤣

$ZEPP Health NYSE Q3 breakdown and deep dive into the company. Very educational. Very interesting https://www.youtube.com/watch?v=3ybdShXg6cs

Happy Festivus everybody

I am with you. Trading this week may lead to very bad decisions. I didn't want to even buy, but... like I said before, I have a bit of a spectrum issue with nice round numbers.

Funny you accuse me of lying when I am strictly referencing SEC documentation concerning SAPX yet you are the one doctoring official SEC documentation (which is illegal).

This is the actual paragraph where you inserted your own (NOT ACCUSED OF ANY WRONG DOING - in red) which is NOT in

Say goodbye. That's all folks!!!!! I just bought and everything I buy turns to sh*t!!!!!!

Bought back NVDA 10 Puts for 65 cents were sold for for $1.22 on 12/06.
Will sell them again, gladly when the NVDA shares go negative.

https://i.postimg.cc/PxdmRqpY/original-556880445.png

I wonder what happened to the Auctus convertible debt????? Was it transferred to shareholders who are now diluting into the market.
Here in an 11/14/2022 OTCQB filing for a 6/30/22 period Auctus is listed in the convertible debt which became payable in Nov 1 2022. This shows an outstanding ba

Patience,

At these levels, accumulate your position, and patiently wait.

I just bought half my agq calls back Friday.
Knock on wood, the signals have been very kind.